Who Paid My Doc
Sudhir Rao
Allergy & Immunology Toledo, OH Medical Doctor
NPI 1396723904 CMS profile 1143408
4235 Secor Rd, Bldg 3, Toledo, OH 43623
General payments
$4,277
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Sudhir Rao of Toledo, OH is reported in the CMS Open Payments database as having received $4,277 across 67 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 54th percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $688 | 19 | |
| 2024 | General | $1,782 | 30 | |
| 2023 | General | $631 | 7 | |
| 2022 | General | $845 | 8 | |
| 2021 | General | $331 | 3 |
Beside peers
- Sudhir Rao
- Allergy & Immunology median
- Middle half of Allergy & Immunology
- National median
In program year 2025, general payments to Sudhir Rao were reported at $688. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.
Show as a table
| Year | Sudhir Rao | Allergy & Immunology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $594 | $163–$1,512 | $163 |
| 2020 | $0 | $426 | $106–$1,233 | $114 |
| 2021 | $331 | $638 | $157–$1,708 | $132 |
| 2022 | $845 | $790 | $205–$1,961 | $149 |
| 2023 | $631 | $852 | $220–$2,147 | $160 |
| 2024 | $1,782 | $865 | $203–$2,267 | $164 |
| 2025 | $688 | $1,140 | $272–$2,892 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 14 billing codesPaid by Medicare
$15,251
Medicare patients
101
Services billed
2,094
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 74% | |
| Arthritis | 54% | |
| Diabetes | 25% | |
| Chronic kidney disease | 23% | |
| Osteoporosis | 17% | |
| Atrial fibrillation | 15% | |
| Depression | 15% | |
| COPD | 14% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
67 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Allergy & Immunology in Ohio
Justin Greiwe
Allergy & Immunology · Cincinnati, OH
Jonathan Bernstein
Allergy & Immunology · Cincinnati, OH
Adam Updegraff
Allergy & Immunology · Toledo, OH
Syed Rehman
Allergy & Immunology · Toledo, OH
Gordon Myers
Allergy & Immunology · Cincinnati, OH
Nancy Wasserbauer Kingston
Allergy & Immunology · Rocky River, OH
Related records
Allergy & Immunology in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Allergy & Immunology
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.